Effects of a Family-Based Lifestyle Intervention Plus Supervised Exercise Training on Abdominal Fat Depots in Children With Overweight or Obesity: A Secondary Analysis of a Nonrandomized Clinical Trial.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
entrez:
28
11
2022
pubmed:
29
11
2022
medline:
1
12
2022
Statut:
epublish
Résumé
Excess abdominal fat is a major determinant in the development of insulin resistance and other metabolic disorders. Increased visceral adipose tissue (VAT) seems to precede the development of insulin resistance and is therefore a prime target of childhood lifestyle interventions aimed at preventing diabetes. To examine the effect of added exercise to a family-based lifestyle intervention program designed to reduce VAT plus subcutaneous (ASAT), intermuscular (IMAAT), and pancreatic (PAT) adipose tissue in children with overweight or obesity and to explore the effect of changes in VAT on insulin resistance. This 2-group, parallel-design clinical trial was conducted in Vitoria-Gasteiz, Spain. A total of 116 children with overweight or obesity participated and were assigned to a 22-week family-based lifestyle program (control group [n = 57]) or the same program plus an exercise intervention (exercise group [n = 59]). Data were collected between September 1, 2014, and June 30, 2017, and imaging processing for fat depot assessments and data analysis were performed between May 1, 2019, and February 12, 2021. The compared interventions consisted of a family-based lifestyle and psychoeducation program (two 90-minute sessions per month) and the same program plus supervised exercise (three 90-minute sessions per week). The primary outcome of this study was the change in VAT between baseline and 22 weeks as estimated by magnetic resonance imaging. The secondary outcomes were changes in ASAT, IMAAT, and PAT. The effect of changes in VAT area on insulin resistance was also recorded. The 116 participants included in the analysis (62 girls [53.4%]) had a mean (SD) age of 10.6 (1.1) years, and 67 (57.8%) presented with obesity. Significantly greater reductions were recorded for the exercise group in terms of reduction in VAT (-18.1% vs -8.5% for the control group; P = .004), ASAT (-9.9% vs -3.0%; P = .001), and IMAAT (-6.0% vs -2.6%; P = .02) fat fractions compared with the control group. Changes in VAT explained 87.6% of the improvement seen in insulin resistance (β = -0.102 [95% CI, -0.230 to -0.002]). These findings suggest that the addition of exercise to a lifestyle intervention program substantially enhanced the positive effects on abdominal fat depots in children with overweight or obesity. In addition, the reduction in VAT seemed to largely mediate the improvement of insulin sensitivity. These results highlight the importance of including exercise as part of lifestyle therapies aimed at treating childhood obesity and preventing the development of type 2 diabetes. ClinicalTrials.gov Identifier: NCT02258126.
Identifiants
pubmed: 36441551
pii: 2799015
doi: 10.1001/jamanetworkopen.2022.43864
pmc: PMC9706365
doi:
Banques de données
ClinicalTrials.gov
['NCT02258126']
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2243864Références
Diabetologia. 2018 Aug;61(8):1817-1828
pubmed: 29717337
Int J Obes Relat Metab Disord. 1999 Aug;23(8):889-95
pubmed: 10490792
JAMA. 2012 Sep 19;308(11):1103-12
pubmed: 22990269
Diabetes Care. 2011 Feb;34(2):485-90
pubmed: 21270204
Int J Obes (Lond). 2021 May;45(5):982-997
pubmed: 33558643
Nutr Diabetes. 2012 Aug 27;2:e42
pubmed: 23168527
Med Sci Sports Exerc. 2016 Jul;48(7):1415-24
pubmed: 27314412
JAMA. 2015 Aug 25;314(8):781-90
pubmed: 26305648
Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1222-9
pubmed: 24045865
Clin Nutr ESPEN. 2018 Apr;24:82-89
pubmed: 29576369
J Pediatr. 2019 Mar;206:91-98.e1
pubmed: 30554789
J Magn Reson Imaging. 2019 Oct;50(4):1092-1102
pubmed: 30701611
N Engl J Med. 2018 Apr 05;378(14):1302-1312
pubmed: 29617589
Obesity (Silver Spring). 2006 Feb;14(2):336-41
pubmed: 16571861
Pancreas. 2017 Mar;46(3):358-365
pubmed: 27941426
J Clin Endocrinol Metab. 2017 Mar 01;102(3):709-757
pubmed: 28359099
Nature. 2006 Dec 14;444(7121):881-7
pubmed: 17167477
Diabetes. 2012 Nov;61(11):2787-95
pubmed: 22751691
Eur J Clin Nutr. 2018 Sep;72(9):1239-1245
pubmed: 30185840
Med Sci Sports Exerc. 2011 Nov;43(11):2195-203
pubmed: 21502883
Med Sci Sports Exerc. 1999 Jan;31(1):143-8
pubmed: 9927022
BMC Med Imaging. 2019 May 14;19(1):38
pubmed: 31088378
Appl Physiol Nutr Metab. 2020 Dec;45(12):1377-1386
pubmed: 32674587
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Diabetes Care. 2020 Feb;43(2):306-313
pubmed: 31227585
Diabetes Care. 2012 Feb;35(2):296-8
pubmed: 22190675
Contemp Clin Trials. 2015 Nov;45(Pt B):346-355
pubmed: 26408054
Endocr Rev. 2000 Dec;21(6):697-738
pubmed: 11133069
J Hepatol. 2021 Aug;75(2):292-301
pubmed: 33865909
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Diabetes Metab. 2016 Nov;42(5):382-385
pubmed: 27283873
JAMA. 2021 Sep 21;326(11):1045-1056
pubmed: 34546296
Sports Med. 2018 Mar;48(3):733-746
pubmed: 28853029
Obesity (Silver Spring). 2014 May;22(5):1280-6
pubmed: 24402863
Pediatr Obes. 2012 Aug;7(4):284-94
pubmed: 22715120
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683